Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-01 | MAXCYTE, INC. | Erck Stanley C
(Director) |
S | Common Stock | D | 47689 | $3.72 - $3.72 | $177,403 |
| 2024-11-01 | MAXCYTE, INC. | Erck Stanley C
(Director) |
M | Common Stock | A | 47689 | $0.04 - $0.04 | $1,907 |
| 2024-10-14 | MAXCYTE, INC. | Collins Cynthia
(Director) |
A | Common Stock | A | 51679 | $0.00 - $0.00 | $0 |
| 2024-09-26 | MAXCYTE, INC. | Johnston John Joseph
(Director) |
S | Common Stock | D | 3000 | $3.82 - $3.82 | $11,460 |
| 2024-09-26 | MAXCYTE, INC. | Johnston John Joseph
(Director) |
M | Common Stock | A | 3000 | $2.93 - $2.93 | $8,778 |
| 2024-09-16 | MAXCYTE, INC. | Soleymannezhad Ali
(Chief Commercial Officer) |
A | Common Stock | A | 10400 | $0.00 - $0.00 | $0 |
| 2024-08-01 | MAXCYTE, INC. | Ross Thomas M.
(EVP, GLOBAL SALES) |
S | Common Stock | D | 33333 | $4.36 - $4.54 | $148,135 |
| 2024-08-01 | MAXCYTE, INC. | Ross Thomas M.
(EVP, GLOBAL SALES) |
M | Common Stock | A | 33333 | $1.64 - $1.64 | $54,699 |
| 2024-07-08 | MAXCYTE, INC. | Ross Thomas M.
(EVP, GLOBAL SALES) |
S | Common Stock | D | 33333 | $4.03 - $4.03 | $134,366 |
| 2024-07-08 | MAXCYTE, INC. | Ross Thomas M.
(EVP, GLOBAL SALES) |
M | Common Stock | A | 33333 | $1.64 - $1.64 | $54,699 |
| 2024-06-27 | MAXCYTE, INC. | Johnston John Joseph
(Director) |
S | Common Stock | D | 10000 | $3.99 - $3.99 | $39,900 |
| 2024-06-27 | MAXCYTE, INC. | Johnston John Joseph
(Director) |
M | Common Stock | A | 10000 | $1.64 - $2.93 | $22,778 |
| 2024-06-20 | MAXCYTE, INC. | Ross Thomas M.
(EVP, GLOBAL SALES) |
S | Common Stock | D | 33333 | $4.09 - $4.09 | $136,465 |
| 2024-06-20 | MAXCYTE, INC. | Ross Thomas M.
(EVP, GLOBAL SALES) |
M | Common Stock | A | 33333 | $1.64 - $1.64 | $54,699 |
| 2024-06-11 | MAXCYTE, INC. | Mandell Art
(Director) |
A | Common Stock | A | 21367 | $0.00 - $0.00 | $0 |
| 2024-06-11 | MAXCYTE, INC. | DOUGLAS RICHARD
(Director) |
A | Common Stock | A | 21367 | $0.00 - $0.00 | $0 |
| 2024-06-11 | MAXCYTE, INC. | Hemrajani Rekha
(Director) |
A | Common Stock | A | 21367 | $0.00 - $0.00 | $0 |
| 2024-06-11 | MAXCYTE, INC. | Erck Stanley C
(Director) |
A | Common Stock | A | 21367 | $0.00 - $0.00 | $0 |
| 2024-06-11 | MAXCYTE, INC. | Al-Wakeel Yasir B.
(Director) |
A | Common Stock | A | 21367 | $0.00 - $0.00 | $0 |
| 2024-06-11 | MAXCYTE, INC. | Johnston John Joseph
(Director) |
A | Common Stock | A | 21367 | $0.00 - $0.00 | $0 |
| 2024-06-11 | MAXCYTE, INC. | Brooke William W
(Director) |
A | Common Stock | A | 21367 | $0.00 - $0.00 | $0 |
| 2024-06-07 | MAXCYTE, INC. | Masoud Maher
(President and CEO) |
P | Common Stock | A | 100000 | $4.87 - $4.90 | $489,065 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |